Initiate fluoxetine 60 mg daily for bulimia nervosa while immediately addressing acute suicide risk and acetaminophen toxicity.
Immediate Medical Priorities
First, ensure medical stabilization from the acetaminophen overdose – obtain acetaminophen levels, liver function tests, and consider N-acetylcysteine if indicated. Simultaneously assess for acute suicide risk requiring inpatient psychiatric hospitalization 1.
Medication Selection for Eating Disorder
For this patient with binge-purge behaviors, start fluoxetine 60 mg daily. The 2023 APA guidelines specifically recommend that adults with bulimia nervosa be treated with eating disorder-focused cognitive-behavioral therapy AND a serotonin reuptake inhibitor (specifically citing 60 mg fluoxetine daily), either initially or if minimal response to psychotherapy alone by 6 weeks 1.
Why Fluoxetine at This Dose:
- Fluoxetine is the only FDA-approved medication for bulimia nervosa 2
- The therapeutic dose for bulimia is 60 mg daily – higher than typical antidepressant dosing
- It addresses both the eating disorder pathology and comorbid depressive symptoms that contribute to suicidality 3
Critical Safety Considerations
Suicide Risk Management
This patient has multiple high-risk features:
- Recent suicide attempt
- History of non-suicidal self-injury (cutting)
- Binge-purge subtype eating disorder (independently associated with suicide attempts) 4, 5
- Alcohol use complicating impulsivity
The binge-purge pattern specifically increases suicide attempt risk beyond other eating disorder presentations 4, 5. Depression and psychiatric comorbidities are key drivers of suicidal ideation in eating disorders 3.
Pre-Medication Workup Required
Per APA guidelines, obtain 1:
- ECG – mandatory in patients with severe purging behavior (QTc prolongation risk)
- Complete blood count
- Comprehensive metabolic panel with electrolytes (purging causes hypokalemia, hypomagnesemia)
- Liver and renal function tests
Treatment Framework
Medication alone is insufficient. The guideline emphasizes a coordinated multidisciplinary approach 1:
- Psychotherapy is primary treatment: Eating disorder-focused CBT should be initiated concurrently, not after medication trial
- Fluoxetine augments psychotherapy: Can be started immediately rather than waiting 6 weeks for psychotherapy response given severity
- Address alcohol use: Complicates both eating disorder and suicide risk
- Monitor purging behaviors: Track frequency as both treatment outcome and medical safety indicator
Common Pitfalls to Avoid
- Don't underdose fluoxetine: 20-40 mg is inadequate for bulimia; 60 mg is the evidence-based dose
- Don't delay psychiatric hospitalization: Active suicidality with recent attempt requires immediate safety intervention
- Don't ignore electrolytes: Purging can cause life-threatening cardiac arrhythmias from electrolyte disturbances
- Don't prescribe bupropion: Contraindicated in eating disorders due to seizure risk
Medication Alternatives
If fluoxetine fails or is not tolerated, other antidepressants have evidence in binge-eating spectrum disorders 6, though fluoxetine remains first-line per guidelines. Lisdexamfetamine is FDA-approved for binge-eating disorder but not bulimia nervosa 2.